493 results
8-K
EX-99.2
BMY
Bristol-Myers Squibb Co.
26 Jul 18
Bristol-Myers Squibb Reports Second Quarter Financial Results
8:05am
Marketing, selling and administrative
Research and development
Other income (net)
Total Expenses
Earnings Before Income Taxes
Provision for Income … and administrative excluding specified items (a)
Marketing, selling and administrative excluding specified items as a % of revenues
Research and development
8-K
EX-99.2
BMY
Bristol-Myers Squibb Co.
22 Jul 10
Bristol-Myers Squibb Second Quarter Featured Robust Clinical Data
12:00am
and administrative
-3%
-2%
Advertising and product promotion
-12%
-13%
Research and development
1%
Provision for restructuring, net
26%
-8%
Litigation … and administrative
19.8%
20.3%
18.8%
18.7%
Advertising and product promotion
6.4%
6.1%
5.5%
5.0%
Research and development
17.4%
19.1%
17.2%
18.1
8-K
EX-99.2
BMY
Bristol-Myers Squibb Co.
26 Apr 07
Bristol-myers Squibb Company Reports First Quarter 2007 Financial Results
12:00am
Marketing, selling and administrative
-6
Advertising and product promotion
-9
Research and development
Provision for restructuring, net
Litigation … and administrative
Advertising and product promotion
Research and development
Total expenses
Earnings/(Loss) Before Minority Interest and Income Taxes
Net
8-K
EX-99.2
BMY
Bristol-Myers Squibb Co.
27 Jan 11
Receives U.S. Regulatory Approval for KOMBIGLYZE™ XR, and First-Line Indication for SPRYCEL® in Fourth Quarter
12:00am
promotion
(19)%
(14)%
Research and development
(9)%
(2)%
Provision for restructuring, net
34%
(17)%
Litigation expense, net
114%
Equity in net … and administrative
23.2%
21.0%
19.6%
18.9%
Advertising and product promotion
6.6%
6.0%
5.3%
5.0%
Research and development
22.0%
19.4%
19.8%
18.3
8-K
EX-99.2
BMY
Bristol-Myers Squibb Co.
15 Mar 04
Other events
12:00am
, and administrative
Advertising and product promotion
Research and development
Provision for restructuring and other items
Litigation charges, net
Equity in net … , selling, and administrative
Advertising and product promotion
Research and development
Acquired in-process research and development
Provision
8-K
EX-99.1
e4xtxbhta2 yrzpib
31 Jan 08
Results of Operations and Financial Condition
12:00am
8-K
EX-99.2
f0tnrumvm2
27 Oct 15
Bristol-Myers Squibb Reports Third Quarter Financial Results
12:00am
8-K
EX-99.2
pw0xw38u
24 Jul 08
Bristol-myers Squibb Continues Strong Financial Performance
12:00am
8-K
EX-99.2
bysou fntdo1it
23 Oct 08
Led By Double-Digit Global Net Sales Growth and Strong Earnings Results
12:00am
8-K
EX-99.2
jw6m63g
31 Oct 19
Bristol-Myers Squibb Reports Third Quarter Financial Results
8:01am
8-K
EX-99.2
2pzckfkw dnu
27 Oct 16
Bristol-Myers Squibb Reports Third Quarter Financial Results
12:00am
8-K
EX-99.2
v9lmnt00ruzz2bf4xi
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
8-K
EX-99.2
larlcnq74bvc
31 Jan 08
Results of Operations and Financial Condition
12:00am
8-K
EX-99.2
ja8kcrornl7udun
27 Jan 09
Strong Fourth Quarter Supports Excellent 2008 for Bristol-Myers Squibb
12:00am
8-K
EX-99.2
cipxxky
23 Jul 15
Bristol-Myers Squibb Reports Second Quarter Financial Results
12:00am
8-K
EX-99.2
3phim qe712x
28 Jan 10
Strong Operational and Strategic Performance in Fourth Quarter Caps Transformative 2009
12:00am
8-K
EX-99.2
1f5q15xf
25 Jul 19
Bristol-Myers Squibb Reports Second Quarter Financial Results
8:21am
8-K
EX-99.2
bxt539aq
24 Apr 08
Strong Double-digit Net Sales Growth and Solid Earnings Growth
12:00am
8-K
EX-99.2
qqi9c83
25 Oct 18
Bristol-Myers Squibb Reports Third Quarter Financial Results
8:02am
8-K
EX-99.2
8f4u25a68m480kyzmkzz
28 Apr 11
Key R&D Milestones and Strong Financials
12:00am